i’ve been following the threads on GLP-1 medications like Mounjaro and their potential to reduce cancer risk. It’s fascinating stuff, and I’m wondering if anyone else has given this much thought. From what I’ve read, the research suggests that GLP-1s might help prevent tumors from spreading.
I’m no expert, but it seems like this could be a game-changer. I’ve been tracking my own health journey with a symptom tracker, and it’s been really helpful to see the trends and correlations between my symptoms. The visual charts and trend lines have been particularly useful in identifying patterns I wouldn’t have noticed otherwise.
Has anyone else explored this connection between GLP-1s and cancer risk? I’d love to hear your thoughts and experiences. 📊
what specific patterns are you seeing for cancer risk?
what specific trends do the visual charts highlight for you?
1 Like
my endo mentioned the metabolic connection years ago when i asked about insulin resistance. it’s not just about glucose numbers, is it?
that whole system is so linked, and when one part is off, it drags everything else down. seeing the data now on tirz or sema doing more than just moving an a1c number
hearing about the potential for something to help prevent tumor spread is definitely a hopeful thought for a lot of people dealing with chronic illness, where so much feels out of control. on your point about tracking patterns, i’ve found those correlation views in the careclinic app to be really helpful too - being able to actually see what flares up when, instead
1 Like